Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy.

MLA

Hoffmann, Marc S., and Siddhartha Ganguly. “Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-Based Chemoimmunotherapy.” Clinical Lymphoma, Myeloma & Leukemia, vol. 21, no. 6, June 2021, pp. e548–50. EBSCOhost, https://doi.org/10.1016/j.clml.2021.02.009.

APA

Hoffmann, M. S., & Ganguly, S. (2021). Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy. Clinical Lymphoma, Myeloma & Leukemia, 21(6), e548–e550. https://doi.org/10.1016/j.clml.2021.02.009

Chicago

Hoffmann, Marc S., and Siddhartha Ganguly. 2021. “Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-Based Chemoimmunotherapy.” Clinical Lymphoma, Myeloma & Leukemia 21 (6): e548–50. doi:10.1016/j.clml.2021.02.009.